ACV AUCTIONS INC-A (ACVA)

US00091G1040 - Common Stock

17.72  -0.24 (-1.34%)

After market: 17.72 0 (0%)

Fundamental Rating

4

ACVA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 84 industry peers in the Commercial Services & Supplies industry. ACVA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ACVA shows excellent growth, but is valued quite expensive already.



2

1. Profitability

1.1 Basic Checks

In the past year ACVA has reported negative net income.
In the past year ACVA has reported a negative cash flow from operations.
ACVA had negative earnings in each of the past 5 years.
In multiple years ACVA reported negative operating cash flow during the last 5 years.

1.2 Ratios

ACVA has a Return On Assets of -8.15%. This is in the lower half of the industry: ACVA underperforms 75.90% of its industry peers.
ACVA has a worse Return On Equity (-16.48%) than 71.08% of its industry peers.
Industry RankSector Rank
ROA -8.15%
ROE -16.48%
ROIC N/A
ROA(3y)-9.09%
ROA(5y)-12.55%
ROE(3y)-17.2%
ROE(5y)-21.46%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 49.20%, ACVA belongs to the best of the industry, outperforming 91.57% of the companies in the same industry.
In the last couple of years the Gross Margin of ACVA has grown nicely.
ACVA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.47%
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

ACVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ACVA has more shares outstanding
ACVA has a worse debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 3.78 indicates that ACVA is not in any danger for bankruptcy at the moment.
ACVA's Altman-Z score of 3.78 is fine compared to the rest of the industry. ACVA outperforms 75.90% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that ACVA is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.25, ACVA is in the better half of the industry, outperforming 66.27% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 3.78
ROIC/WACCN/A
WACC9.02%

2.3 Liquidity

ACVA has a Current Ratio of 2.12. This indicates that ACVA is financially healthy and has no problem in meeting its short term obligations.
ACVA's Current ratio of 2.12 is fine compared to the rest of the industry. ACVA outperforms 71.08% of its industry peers.
ACVA has a Quick Ratio of 2.12. This indicates that ACVA is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of ACVA (2.12) is better than 80.72% of its industry peers.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 2.12

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 41.54% over the past year.
Looking at the last year, ACVA shows a quite strong growth in Revenue. The Revenue has grown by 14.13% in the last year.
ACVA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 32.18% yearly.
EPS 1Y (TTM)41.54%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q6.67%
Revenue 1Y (TTM)14.13%
Revenue growth 3Y32.18%
Revenue growth 5YN/A
Revenue growth Q2Q20.79%

3.2 Future

The Earnings Per Share is expected to grow by 54.27% on average over the next years. This is a very strong growth
Based on estimates for the next years, ACVA will show a very strong growth in Revenue. The Revenue will grow by 26.11% on average per year.
EPS Next Y9.01%
EPS Next 2Y47.19%
EPS Next 3Y54.61%
EPS Next 5Y54.27%
Revenue Next Year27.46%
Revenue Next 2Y26.55%
Revenue Next 3Y30.6%
Revenue Next 5Y26.11%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

ACVA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ACVA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

ACVA's earnings are expected to grow with 54.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.19%
EPS Next 3Y54.61%

0

5. Dividend

5.1 Amount

ACVA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ACV AUCTIONS INC-A

NASDAQ:ACVA (4/25/2024, 7:00:00 PM)

After market: 17.72 0 (0%)

17.72

-0.24 (-1.34%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.90B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.15%
ROE -16.48%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 49.2%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.12
Quick Ratio 2.12
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)41.54%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y9.01%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)14.13%
Revenue growth 3Y32.18%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y